Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wadler

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbationJ A Sparano, S Wadler, R B Diasio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinomaS Wadler, E L Schwartz, M Goldman, et al.
Gynecologic Oncology|March 1, 1995
A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancerJ L Speyer, J Mandeli, H Hochster, et al.
Journal of the National Cancer Institute|November 18, 1992
Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicinH Hochster, L Liebes, S Wadler, et al.
Investigational New Drugs|December 16, 1998
A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neckJ J Beitler, R V Smith, H Haynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupM Markman, B N Bundy, D S Alberts, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1997
Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?J J Beitler, P S Anderson, S Wadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group studyS Wadler, J J Beitler, J S Rubin, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
Lack of efficacy of interferon-alpha therapy in recurrent, advanced cervical cancerS Wadler, R D Burk, D Neuberg, et al.
Cancer|May 15, 1994
New barriers to ventricular invasion in paraglottic laryngeal cancerJ J Beitler, P S Mahadevia, C E Silver, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbationJ A Sparano, S Wadler, R B Diasio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinomaS Wadler, E L Schwartz, M Goldman, et al.
Gynecologic Oncology|March 1, 1995
A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancerJ L Speyer, J Mandeli, H Hochster, et al.
Journal of the National Cancer Institute|November 18, 1992
Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicinH Hochster, L Liebes, S Wadler, et al.
Investigational New Drugs|December 16, 1998
A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neckJ J Beitler, R V Smith, H Haynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupM Markman, B N Bundy, D S Alberts, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1997
Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?J J Beitler, P S Anderson, S Wadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group studyS Wadler, J J Beitler, J S Rubin, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
Lack of efficacy of interferon-alpha therapy in recurrent, advanced cervical cancerS Wadler, R D Burk, D Neuberg, et al.
Cancer|May 15, 1994
New barriers to ventricular invasion in paraglottic laryngeal cancerJ J Beitler, P S Mahadevia, C E Silver, et al.
Pageof 14